Better HIV and STI screening and PrEP access in primary care
Part of Immune system & allergy, Infections clinical trials.
This study tests a program that helps clinics in Mississippi integrate HIV and STI screening with PrEP (a daily pill that prevents HIV) into regular primary care visits. If you're a patient at one of these clinics, the program may make it easier to get tested and started on PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You receive primary care at a participating clinic in Canton or Yazoo City, Mississippi.
- You can read and understand English for surveys and interviews.
- You are not critically ill, psychiatrically unstable, or unable to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study looks at how telehealth can make PrEP (medication that helps prevent HIV) easier to get, by partnering with community organizations in Philadelphia. Researchers want to interview or survey clients and staff to understand what works and what could be improved.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study looks at ways to help Black teens and young adults in Alabama get and use PrEP, a medicine that prevents HIV. It involves you and a support person working together with the study team to make taking PrEP easier.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.